Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 362

1.

The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension.

Bharani A, Mathew V, Sahu A, Lunia B.

Indian Heart J. 2003 Jan-Feb;55(1):55-9.

PMID:
12760589
2.
3.

Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.

Simonneau G, Rubin LJ, Galiè N, Barst RJ, Fleming TR, Frost AE, Engel PJ, Kramer MR, Burgess G, Collings L, Cossons N, Sitbon O, Badesch DB; PACES Study Group.

Ann Intern Med. 2008 Oct 21;149(8):521-30. Erratum in: Ann Intern Med. 2009 Jan 6;150(1):63. Ann Intern Med. 2009 Sep 15;151(6):435.

PMID:
18936500
4.

Sildenafil citrate therapy for pulmonary arterial hypertension.

Galiè N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, Fleming T, Parpia T, Burgess G, Branzi A, Grimminger F, Kurzyna M, Simonneau G; Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group.

N Engl J Med. 2005 Nov 17;353(20):2148-57. Erratum in: N Engl J Med. 2006 Jun 1;354(22):2400-1.

5.

Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.

Ghofrani HA, Wiedemann R, Rose F, Olschewski H, Schermuly RT, Weissmann N, Seeger W, Grimminger F.

Ann Intern Med. 2002 Apr 2;136(7):515-22.

PMID:
11926786
6.

Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension.

Ghofrani HA, Rose F, Schermuly RT, Olschewski H, Wiedemann R, Kreckel A, Weissmann N, Ghofrani S, Enke B, Seeger W, Grimminger F.

J Am Coll Cardiol. 2003 Jul 2;42(1):158-64.

7.

Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.

Lewis GD, Shah R, Shahzad K, Camuso JM, Pappagianopoulos PP, Hung J, Tawakol A, Gerszten RE, Systrom DM, Bloch KD, Semigran MJ.

Circulation. 2007 Oct 2;116(14):1555-62. Epub 2007 Sep 4.

8.

Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial.

Galiè N, Humbert M, Vachiéry JL, Vizza CD, Kneussl M, Manes A, Sitbon O, Torbicki A, Delcroix M, Naeije R, Hoeper M, Chaouat A, Morand S, Besse B, Simonneau G; Arterial Pulmonary Hypertension and Beraprost European (ALPHABET) Study Group.

J Am Coll Cardiol. 2002 May 1;39(9):1496-502.

9.

Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.

Michelakis ED, Tymchak W, Noga M, Webster L, Wu XC, Lien D, Wang SH, Modry D, Archer SL.

Circulation. 2003 Oct 28;108(17):2066-9. Epub 2003 Oct 20.

10.

Efficacy and safety of PDE-5 inhibitor tadalafil in pulmonary arterial hypertension.

Bharani A, Patel A, Saraf J, Jain A, Mehrotra S, Lunia B.

Indian Heart J. 2007 Jul-Aug;59(4):323-8.

PMID:
19126937
11.

Chronic oral sildenafil therapy in severe pulmonary artery hypertension.

Kothari SS, Duggal B.

Indian Heart J. 2002 Jul-Aug;54(4):404-9.

PMID:
12462669
12.
13.

Phosphodiesterase type 5 and high altitude pulmonary hypertension.

Aldashev AA, Kojonazarov BK, Amatov TA, Sooronbaev TM, Mirrakhimov MM, Morrell NW, Wharton J, Wilkins MR.

Thorax. 2005 Aug;60(8):683-7.

14.

Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship.

Garg N, Sharma MK, Sinha N.

Int J Cardiol. 2007 Sep 3;120(3):306-13. Epub 2006 Dec 15.

PMID:
17174417
15.

Sildenafil therapy and exercise tolerance in idiopathic pulmonary fibrosis.

Jackson RM, Glassberg MK, Ramos CF, Bejarano PA, Butrous G, Gómez-Marín O.

Lung. 2010 Apr;188(2):115-23. doi: 10.1007/s00408-009-9209-8. Epub 2009 Dec 12.

PMID:
20012639
16.

Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.

Keogh AM, Jabbour A, Weintraub R, Brown K, Hayward CS, Macdonald PS.

J Heart Lung Transplant. 2007 Nov;26(11):1079-83. Epub 2007 Oct 24.

PMID:
18022071
17.

Efficacy and optimal dose of sildenafil in primary pulmonary hypertension.

Chockalingam A, Gnanavelu G, Venkatesan S, Elangovan S, Jagannathan V, Subramaniam T, Alagesan R, Dorairajan S.

Int J Cardiol. 2005 Mar 10;99(1):91-5.

PMID:
15721505
18.

Sildenafil for primary and secondary pulmonary hypertension.

Watanabe H, Ohashi K, Takeuchi K, Yamashita K, Yokoyama T, Tran QK, Satoh H, Terada H, Ohashi H, Hayashi H.

Clin Pharmacol Ther. 2002 May;71(5):398-402.

PMID:
12011826
19.

Sildenafil for pulmonary hypertension secondary to congenital heart diseases.

Gupta A, Kerkar P.

Indian Heart J. 2007 Jul-Aug;59(4):342-5.

PMID:
19126940
20.

Sildenafil therapy for pulmonary arterial hypertension associated with atrial septal defects.

Lim ZS, Salmon AP, Vettukattil JJ, Veldtman GR.

Int J Cardiol. 2007 May 31;118(2):178-82. Epub 2006 Oct 5.

PMID:
17027100

Supplemental Content

Support Center